|
|
111 W. Evelyn Avenue, Suite 309
Sunnyvale, CA 94086 USA
phone:(408)830.0591
fax:
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.neuralieve.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Using transcranial magnetic stimulation to treat migraine headache. |
|
| Management |
| Gary H. Stroy, President and Chief Executive Officer; Robert E. Fischell, ScD, Founder and Chief Technology Officer; Ting W. Lu, Chief Financial Officer; Lorine S. Tanimoto, Director, Clinical Operations; James L. Wilson, Director, Marketing and Sales |
| |
|
|
| |
|
| Keywords |
| portable device, migraine, magnet, magnetic, stimulation, headache, tms, transcranial, magnetic, stimulation |
|
|
|
| Description |
|
Neuralieve is pursuing a completely novel approach to the treatment of migraine headache. The company's core technology is based on the science of transcranial magnetic stimulation (TMS), a modality that has been used extensively in brain research and proven to be exceedingly safe. |
|
| Products / Services |
Neuralieves investigational TMS device is a self-contained apparatus that delivers treatments consisting of a limited number of pulses of magnetic energy. Intended for use at home by patients, the device is small, lightweight and portable.
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members